Quon, Harvey <br/><br/>
Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Jun 2012 
 - 617-23 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2011.07.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Androgen Antagonists--therapeutic use<br/>Dose Fractionation, Radiation<br/>Femur Head--diagnostic imaging<br/>Humans<br/>Male<br/>Neoplasm Staging<br/>Organs at Risk--diagnostic imaging<br/>Prospective Studies<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Quality of Life<br/>Radiography<br/>Radiotherapy, Intensity-Modulated--methods<br/>Rectum--diagnostic imaging<br/>Risk<br/>Urinary Bladder--diagnostic imaging